JFL Life Sciences Limited (NSE:JFLLIFE)
India flag India · Delayed Price · Currency is INR
11.80
+0.55 (4.89%)
At close: Jul 28, 2026

JFL Life Sciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,3141,314820.42470.19442.1343.1
Revenue Growth
60.14%60.14%74.49%6.35%28.85%4.70%
Gross Profit
164.03164.03157.0769.1792.784.3
Operating Income
106.36106.3672.0746.1148.757
Net Income
64.0164.0141.593328.128
Earnings Per Share
1.941.941.261.000.971.37
EPS Growth
53.97%53.97%26.00%3.57%-29.52%346.69%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
14.6214.620.644.410.61.9
Total Debt
217.29217.29105.956.9271.8158.5
Net Cash (Debt)
-202.67-202.67-105.26-52.51-71.2-156.6
Net Cash Growth
------
Net Cash Per Share
-6.14-6.14-3.19-1.59-2.45-7.66

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-43.31-43.31-35.3284.08-90.523.3
Capital Expenditures
-33.79-33.79-3.95-61.13--17
Free Cash Flow
-77.09-77.09-39.2722.95-90.56.3
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
12.48%12.48%19.14%14.71%20.97%24.57%
Operating Margin
8.09%8.09%8.78%9.81%11.02%16.61%
Pretax Margin
6.55%6.55%7.48%8.07%8.41%11.05%
Profit Margin
4.87%4.87%5.07%7.02%6.36%8.16%
FCF Margin
-5.87%-5.87%-4.79%4.88%-20.47%1.84%

Dividends

Fiscal YearFY 2024
Period EndingMar '24
Dividend Per Share
0.083
Dividend Per Share Growth
-
Dividend Yield
0.67%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
6.084.4113.8513.1112.92-
P/FCF Ratio
---18.86--
PS Ratio
0.300.220.700.920.82-